SHL Medical showcases drug delivery solutions at ObesityWeek 2025

SHL Medical is pleased to announce our debut at ObesityWeek® 2025, taking place at Georgia World Congress Center between November 4-6. Visit us to learn how SHL Medical is at the forefront of self-injection solutions for cardiometabolic care, as we continue to innovate to address evolving pharma and patient needs.

With global obesity rates on the rise, demand for self-injection solutions for GLP-1 RAs continues to grow. Since 2015, SHL Medical has supported the launch of six combination products indicated for cardiometabolic diseases. In 2024 alone, we delivered 78.7 million devices in this therapeutic area, reaching 3 million patients worldwide. At the heart of this success is our Molly® modular platform autoinjector. To date, the platform has supported 21+ distinct combination product approvals across 28 indications, and continues to play a key role in cardiometabolic care.

At our tabletop, discover how SHL Medical supports the treatment of cardiometabolic diseases with our innovative device portfolio and our end-to-end manufacturing capabilities. Get hands-on experience with Molly, as well as our newly launched dual-chamber Reunite™ autoinjector for lyophilized formulations, and our large-volume cartridge-based Maggie® autoinjectors.

To ensure a reliable supply for GLP-1 RA therapies at scale, SHL Medical continues to expand our global manufacturing capabilities. Earlier this year, we held the grand opening of our 360,000-square-foot facility in North Charleston, South Carolina. This site complements our operations in Deerfield Beach, Florida, which provides final assembly, labeling, and packaging services. Together, these facilities optimize autoinjector supply by enabling faster access, reducing complexity, and lowering carbon footprint across North America and beyond.

Talk to our representatives to learn how we can support your next cardiometabolic combination product launch. We look forward to connecting with you at Tabletop #916.

Where : Georgia World Congress Center, Atlanta, USA | Tabletop #916

When  : November 4-6